Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CORCEPT-THERAPEUTICS-INCO-40449488/news/Corcept-Completes-Enrollment-in-Phase-2-DAZALS-Trial-in-Patients-With-Amyotrophic-Lateral-Sclerosis-46434868/?utm_source=whatsapp&utm_medium=social&utm_campaign=share